Frequently Asked Questions

The U.S. Department of Justice is actively pursuing an investigation into alleged Medicare fraud involving the unauthorized use of senior citizens' ID numbers across several states to order COVID-19 tests that were neither requested nor needed.

According to a healthcare fraud prosecutor within the Justice Department, who has chosen to remain anonymous due to the ongoing nature of the investigation, there have been instances where rapid tests were billed under the names of deceased individuals. This investigation is still in its early stages, and federal authorities are only beginning to understand the full extent of the alleged fraud, which involves hundreds of thousands of tests and affects seniors and their families in at least 10 states.

A Closer Look at the Context and Challenges Faced by Providers

It is important to recognize that these allegations arise in the context of the federal government’s response to a significant public health emergency. In an effort to address the nationwide shortage of COVID-19 tests during the 2021 holiday season, the Biden administration moved quickly to expand access to free tests in early 2022. Unfortunately, the rapid deployment of this initiative may have led to unintended consequences, including the potential for misuse by third parties.

While there are claims of widespread fraud, it is crucial to approach these allegations with caution. Providers who participated in the government's efforts to distribute tests were operating under extraordinary circumstances and were responding to an urgent need to make testing available to vulnerable populations. The alleged actions of a few bad actors should not overshadow the broader context in which these providers were working.

Moreover, it is worth noting that the Centers for Medicare & Medicaid Services (CMS) has received only a small number of complaints relative to the total number of Medicare beneficiaries. The majority of providers acted in good faith and within the bounds of the law.

Advocating for Fair Investigations: Defending Providers Amid Pandemic-Related Fraud Allegations

As legal counsel for providers, we will continue to advocate for a fair and balanced investigation that considers the unprecedented challenges faced during the pandemic. It is essential that the government’s response to these allegations does not unjustly penalize those who were genuinely trying to help during a time of crisis. We remain committed to defending our clients against any unwarranted claims and ensuring that justice is served.

MORE ARTICLES BY CATEGORY

Get a Free Case REVIEW

100% Confidential & Secure. Your details are safe with us.

We'll speak soon!

In the meantime, why not find out more about us or visit our blog.

Alternatively, give us a call at (800) 345 - 4125

Oops! Something went wrong while submitting the form.

Italian Gold Broker Criminally Charged in $86 Million Customs Duty and Tariff Evasion Scheme Released on Bail

Italian national Claudio Fogale was released from federal jail after his attorney, Anthony J. Mahajan, successfully argued that the evidence was weak and legal requirements were ambiguous.

Read More >>

PBM Enforcement Trends Independent Pharmacies Must Prepare for in 2026

Independent pharmacies are heading into 2026 under tighter PBM oversight, more aggressive audit practices, and evolving reimbursement models driven by regulatory pressure and DIR fee reform. To survive in this environment, pharmacies must strengthen compliance, documentation, and inventory controls while partnering with experienced PBM counsel to manage audits, protect reimbursements, and avoid network termination.

Read More >>

PBM Audit Triggers: Understanding How Prescription Activity Is Evaluated

Pharmacy benefit managers (PBMs) increasingly use data analytics and algorithmic surveillance to identify “red flag” prescriptions and atypical dispensing patterns, which can trigger audits, recoupments, network terminations, and payment withholds for independent pharmacies. By understanding common PBM risk indicators and implementing strong compliance practices, internal audits, documentation, and timely legal support, pharmacies can reduce exposure and more effectively defend themselves during PBM reviews and appeals.

Read More >>

Health Law Alliance Successfully Reverses OptumRx’s Network Termination for a Michigan Pharmacy

We are proud to announce that the Health Law Alliance has successfully reversed a network termination from OptumRx for a Michigan-based independent pharmacy.

Read More >>